2110. Treatment of Coccidioidomycosis with Isavuconazole

Christina Jamros(Naval Medical Center San Diego), Catherine M Berjohn(Henry M. Jackson Foundation), Patricia E Chinn(Naval Medical Center San Diego), Joshua Fierer(San Francisco VA Medical Center), Kathy Tang(Naval Medical Center San Diego), Scott Johns(VA San Diego Healthcare System), Ryan C. Maves(Naval Medical Center San Diego)

Open Forum Infectious Diseases

October 1, 2019

10.1093/ofid/ofz360.1790

Cited by 0

Related Papers

Baricitinib versus dexamethasone for adults hospitalised with COVID-19 (ACTT-4): a randomised, double-blind, double placebo-controlled trial

|The Lancet Respiratory Medicine|2022|128

Persistent COVID-19 Symptoms at 6 Months After Onset and the Role of Vaccination Before or After SARS-CoV-2 Infection

|JAMA Network Open|2023|91

Antigenic cartography of well-characterized human sera shows SARS-CoV-2 neutralization differences based on infection and vaccination history

|Cell Host & Microbe|2022|72

Understanding “Hybrid Immunity”: Comparison and Predictors of Humoral Immune Responses to Severe Acute Respiratory Syndrome Coronavirus 2 Infection (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19) Vaccines

|Clinical Infectious Diseases|2022|59

Trial Evaluating Ambulatory Therapy of Travelers’ Diarrhea (TrEAT TD) Study: A Randomized Controlled Trial Comparing 3 Single-Dose Antibiotic Regimens With Loperamide

|Clinical Infectious Diseases|2017|58